SaaS Founder's Exit Guide.

Valuations for B2B SaaS companies in the lower-middle market ($3M–$50M ARR) typically fall in the 3x to 6x ARR range, though premium assets can command 6x–10x+. The days of "growth at all costs" yielding 20x multiples are largely gone. Today, buyers prioritize efficient growth. Your specific multiple depends on three core levers: Growth Rate (is it >30%?), Retention (is NRR >105%?), and Profitability (Rule of 40). A company growing 40% YoY with strong profitability will trade at the top of the range, while a flat-growth company may trade closer to 1.5x–2.5x ARR or be valued on EBITDA instead.

In 2021, capital was effectively free, driving an anomaly where buyers paid for growth at any cost. Since then, interest rates rose and the cost of capital increased, shifting buyer focus from raw top-line growth to unit economics and capital efficiency. A company that sold for 10x revenue in 2021 might sell for 5x–6x in today's normalized market. This isn't a lowball — it is a return to historical averages. The good news is that deal certainty has improved; buyers active today are serious, disciplined, and have committed capital.

It depends on your growth stage and profitability. ARR multiples: used for high-growth SaaS companies (typically growing >30% YoY) where profits are reinvested into sales and marketing. Buyers pay for future scale. EBITDA multiples: used for slower-growth, mature, or steady-state software businesses (growing <15% YoY). Here, buyers act like private equity, valuing the cash flow the business generates today. The hybrid: many deals in the $5M–$20M range are valued on a blend, or a floor based on EBITDA with a premium for IP and customer stickiness.

Add-backs are expenses added back to your bottom line to show your pro forma or adjusted EBITDA — effectively, what the business would earn if the buyer owned it. Standard SaaS add-backs include: Founder compensation: the difference between your actual salary and a market-rate replacement CEO. Personal expenses: travel, vehicles, or memberships not strictly for business. One-time IT costs: server migrations, major refactoring, non-recurring implementation fees. Professional fees: legal or consulting fees related to the M&A process itself. R&D capitalization: certain development costs that can be capitalized rather than expensed.

NRR is often the single biggest driver of premium multiples. An NRR of 100% is the baseline expectation for B2B SaaS. <90% NRR: signals a leaky bucket. This kills valuations, often dropping multiples by 1–2 turns because buyers model a shrinking customer base. 100%–110% NRR: healthy. Supports standard market multiples. >120% NRR: premium territory. This proves your product expands within accounts automatically. Buyers will pay 1x–3x higher revenue multiples for this negative churn because it guarantees efficient growth without high sales spend.

The Rule of 40 states that your Annual Revenue Growth Rate (%) + EBITDA Margin (%) should equal 40 or higher. 35% growth + 5% profit = 40 (pass). 10% growth + 30% profit = 40 (pass). 15% growth + 5% profit = 20 (fail). Passing this threshold serves as a quality gate for private equity buyers — companies above 40 typically command valuation premiums of 30–50%. Composition matters too: strategic buyers prioritize the growth side; financial buyers prioritize the profit side. Companies falling well below 40 are viewed as distressed or requiring a turnaround, which compresses valuation.

If your growth has plateaued but you generate strong cash flow, you enter cash-cow territory. You will likely be valued on a multiple of SDE or EBITDA rather than revenue — typically 4x–7x EBITDA. While you won't get a 10x revenue multiple, these exits are often highly lucrative because the deal structure typically includes more cash at close and less contingent earnout risk. The buyer pool shifts to private equity firms looking for platform or add-on acquisitions.

Technical debt rarely lowers the headline price in the LOI, but it frequently destroys value during due diligence (the re-trade). If a code audit reveals your platform cannot scale without a rewrite — monolithic architecture, obsolete language, security flaws — buyers may walk away entirely, increase the escrow holdback to cover fix costs, or lower the price by the estimated cost of the rewrite. Disclosing known tech debt early with a remediation plan protects value better than letting a buyer discover it later.

The spread comes down to risk vs. growth. 10x companies have must-have products (high retention), huge TAM, proprietary IP, and >50% growth. Buyers pay for the chance to own a category leader. 2x companies often sell nice-to-have tools (high churn), rely on services revenue (lower margin), have high customer concentration, or use outdated tech stacks. Buyers are paying only for current cash flow, discounting heavily for the risk the business might shrink.

Platform asset: a company large enough ($10M+ ARR) to serve as a foundation for a PE firm to buy other companies. These command the highest multiples because of their strategic value. Bolt-on (add-on): a smaller company (<$5M ARR) bought to be merged into an existing platform, typically trading at lower multiples. The goal: specialized advisors work to position even smaller companies as strategic entries into new verticals to fight for a platform premium.

Only if they drive ROI, not just hype. In 2023/2024, mentioning AI boosted interest. In 2026, buyers scrutinize AI readiness. Valuable: AI that reduces your own delivery costs or automatically upsells customers — measurable financial impact. Not valuable: a wrapper around ChatGPT that competitors can easily copy. Buyers pay premiums for proprietary data sets that train AI, rather than the AI features themselves.

AI-native companies are priced on a different framework than traditional SaaS. Three frameworks are in circulation: ARR-multiple (premium bracket): AI-native companies with durable revenue and defensible model architecture can clear premiums of 1.5x–2.5x over comparable AI-feature SaaS. Talent and IP value (acqui-hire): for earlier-stage AI companies, valuation is built on the team, model performance, and proprietary training data — priced per-engineer plus an IP premium. License-plus-acquisition (hybrid): a strategic buyer licenses the technology upfront, then acquires the company at a structured price. The diligence gap: AI-specific diligence covers data provenance, model defensibility, AI revenue attribution, inference economics, and IP risk. Founders without pre-built answers lose 15–25% of headline value through re-trades.

High NRR (>110%) can mask a leaky bucket if your gross retention is low (<85%). If you lose 15% of customers but upsell the rest massively to hit 110% NRR, buyers view your product as unstable. Private equity firms often use 90% GRR as a hard go/no-go threshold. Below that, they assume product-market-fit issues regardless of your upsell success. Fix GRR leaks 12 months before an exit — it is the hardest metric to explain away.

Services revenue drags down your blended multiple. SaaS revenue is valued at 4x–8x (80%+ gross margins, recurring); services revenue at 1x–1.5x (30% margins, non-recurring). If 30% of your revenue is services, your overall multiple might drop from 6x to 4.5x. We often advise restructuring contracts to productize services or move them to implementation fees to minimize the drag.

Capital efficiency is the #1 metric for 2026 buyers. <9 months: best in class — commands a premium. 12 months: the standard benchmark. >18 months: a valuation-penalty zone. Unless you sell large enterprise contracts (ACV >$100k) with massive LTV, a long payback period signals growth that is too expensive to sustain.

Usage-based models are popular but risky for M&A. Buyers hate unpredictability — if revenue fluctuates wildly month-to-month, they may discount your valuation 10–20% versus a flat-rate subscription model. To get full value, show committed floors in your contracts or cohort analysis proving usage consistently expands over time (120%+ NRR). Without that data, buyers treat your revenue as re-occurring rather than recurring.

A QofE report verifies profits; a QofR report attacks the stability of your revenue. Buyers use it to lower price by identifying fake recurring revenue (one-time fees booked as ARR), churn risks (customers who gave notice but remain in the data), and down-sell risks (over-provisioned customers). Defense: conduct a sell-side QofR audit before going to market to proactively remove dirty data points from the ARR calculation, preventing a mid-deal price drop.

If one customer accounts for >20% of ARR, it won't just lower valuation — it changes the terms. Buyers will likely demand a concentration holdback: on a $20M sale, they might hold $4M in escrow for 1–2 years, released only if that customer stays. Negotiate specific release triggers — e.g., immediate release if the customer renews — rather than arbitrary dates.

Sophisticated buyers, especially growth equity, have moved beyond the simple Rule of 40. The Rule of X weighs growth more heavily: (2 × Growth) + Profit. If you are growing 50% with -10% margin, the Rule of 40 scores you 40; the Rule of X scores you 90. This helps high-growth/high-burn founders argue for higher valuations by emphasizing that their growth is worth the burn.

The SaaS Capital Index has compressed sharply, driven by concern that agentic AI will erode seat-based licensing. For private lower-middle market founders the impact is real but lagged 6–18 months. Buyers are more selective, scrutinizing AI defensibility, seat-count durability, and GRR. What holds value: vertical SaaS with embedded workflows, proprietary training data, replacement cost above license cost, outcome- or usage-based pricing. What faces compression: horizontal point solutions and UI-first tools an AI-native competitor could replicate in 12–18 months. The evidence buyers want: stable or growing seat counts, GRR above 90%, and customers actively expanding usage — documented before going to market.

Waiting for a recovery is not a strategy if the repricing is structural rather than cyclical. The 2022–2023 correction was cyclical and multiples recovered. The 2026 repricing reflects genuine uncertainty about whether seat-based recurring revenue is durable in an agentic AI world — that does not resolve on a predictable timeline. The case for moving now: PE dry powder is at record levels, private multiples still lead public repricing by 6–18 months, and active buyers have committed capital. The case for waiting: your business has genuine AI defensibility and materially improving metrics over the next 12–18 months. The question we ask every founder: are you waiting because your business will genuinely be worth more — or because you hope the market returns to where it was? Only one justifies waiting.

A majority recapitalization is the underused middle path. A PE firm acquires 60–80% of the company; you take substantial cash at close, roll 20–40% equity into the new structure, and continue operating for 3–5 years. At the next sale, your rolled equity participates at the (typically higher) valuation. The second-bite math: on a $50M deal rolling 30%, you take $35M now and $15M rolled. If the company doubles under PE ownership, that rollover is worth $30M — $65M total vs. $50M from a full sale. Recap fits when you are profitable, growing, want liquidity but not an exit, and accept board governance. Full sale fits when you are genuinely done, growth is plateauing, or a strategic offers full value plus synergies PE can't replicate.

An exclusively sell-side advisor is structurally better aligned with founder outcomes. When your advisor also represents PE firms and strategics on buy-side mandates, those buyers are repeat clients — your deal is one transaction, the buyer is a 10-year relationship. The conflict shows up subtly: an advisor who is "realistic" about a price gap, slow to push back on aggressive earnouts, or frames a re-trade as reasonable. The practical test: ask any advisor whether they take buy-side mandates, what share of revenue it represents, and which buyers they currently represent. Exclusively sell-side firms — including iMerge — never represent buyers; the only client is the founder. At $100M+ EBITDA the scale of large dual-advisory firms can outweigh the conflict; below that, alignment wins.

Founder exits carry dynamics corporate divestitures don't — and buyers underwrite all of them. First-time sellers: PE buyers do dozens of deals a year; you are doing this once. The advisor is part financial guide, part coach. Key-person risk: buyers often assume the founder is the business, shaping structure toward aggressive earnouts and retention terms unless addressed proactively. Relationships: founders have personal ties to key customers and employees who may not know the business is for sale — confidentiality protocol and disclosure sequencing must protect them. Valuation anchoring: founders anchor to lifestyle goals or a competitor's 2021 exit; expectations must be aligned to current data before going to market. Post-close reality: earnouts, non-competes, and escrows need to be understood at the LOI phase, not after signing.

Buyers price key-person risk into structure, not headline valuation: 1. Earnouts — tying 20–40% of price to founder commitment over 2–4 years. 2. Escrow — extending to 18–24 months and 15–20% holdbacks when risk is high. 3. Retention pools — 5–10% of deal value set aside for key employees over 2–3 years. Reduce it before market: document institutional knowledge, transition top-customer relationships to your team 12–18 months ahead, build a second-tier management bench with 18+ months tenure, and pre-build a documented transition plan. Unaddressed key-person risk can effectively reduce founder proceeds 15–30% through structure even at the same headline number.

Earnouts bridge the gap between what a seller wants and what a buyer will pay. The metric you choose determines your probability of payment. ARR earnouts: preferred by founders — tied to top-line growth, harder for a buyer to manipulate. EBITDA earnouts: preferred by buyers — risky for founders because the buyer controls expenses post-close and can artificially depress EBITDA. iMerge advice: avoid earnouts if possible; seek seller notes, rolled-over equity, or a larger escrow instead. If you must, go for revenue-based earnouts with strict operating covenants preventing the buyer from loading costs onto your P&L.

Rollover equity (keeping 10–30% of your stake) is standard in PE deals and can be the most lucrative part of the exit — the second bite of the apple. If the PE firm triples the platform's value in 3–5 years, your 20% rollover could be worth more than your initial 80% cash-out. Protection: ensure your rollover shares are pari passu (same class) as the PE firm's shares — the same liquidation preference and rights, not a subordinate class that gets wiped out in a mediocre exit.

NWC is the most common point of friction in the final days of a deal. The buyer expects the business to come with enough gas in the tank (current assets minus current liabilities) to operate normally. Buyers try to set a high NWC peg; if your actual NWC at close is below it, they reduce the price dollar-for-dollar. SaaS specific: deferred revenue often makes NWC negative. Sophisticated advisors argue that cash-free/debt-free means the seller keeps the cash, and deferred revenue should be excluded or normalized so you aren't penalized for collecting cash upfront.

Stock sale: you sell your shares; the buyer takes the whole entity and its liabilities. You typically pay long-term capital gains (~20% federal). If eligible for QSBS (Section 1202), you might pay 0% federal tax on the first $10M+. Asset sale: the buyer purchases individual assets and leaves the legal shell. This can trigger double taxation and higher ordinary income rates. Buyers prefer asset sales for the step-up in basis — sellers should demand a gross-up (higher price) to offset the extra tax hit.

RWI is an insurance policy that replaces the traditional escrow holdback. Old way: 10% of your price sits in escrow for 18 months. New way: the buyer purchases a policy covering those risks and you get ~99% of your cash at close. Policies cost 2–3% of the coverage limit. For deals over $20M, RWI is now standard and highly recommended — it maximizes cash at close.

This defines how long you are on the hook after selling. General reps cover operational matters ("our code doesn't infringe patents") — typically 12–18 months. Fundamental reps cover core legal facts ("I actually own these shares") — indefinite or 6 years. Negotiation point: never allow IP reps to be treated as fundamental. They should expire with general reps to limit long-term liability.

For most $5M–$50M SaaS deals, antitrust risk is minimal — but when the buyer is a dominant strategic in your category, price the risk into the LOI. A blocked deal means 6–12 months of disruption, leaked competitive information, and departing employees. Defenses: negotiate a reverse termination fee (4–8% of deal value if regulators block); push for hell-or-high-water provisions committing the buyer to accept remedies; set a hard outside date (9–12 months). EU and UK review layers can extend timelines when your buyer or customers have meaningful exposure there. A 5% higher headline price from a buyer facing 50% block risk is often worse than a clean deal slightly lower.

A pro-sandbagging clause allows the buyer to sue you for a breach of warranty even if they knew about the breach before closing — they spot an issue in diligence, say nothing, close, then claim damages. Defense: fight for an anti-sandbagging clause stating that if the buyer had knowledge of an issue prior to closing, they cannot later claim damages for it.

The disclosure schedules are the only place you can legally confess your company's flaws to avoid being sued later. You (the company) and your lawyers create them. If the purchase agreement says "the company has no litigation," you use the schedule to list the exceptions. Over-disclose everything: if it's on the schedule, the buyer accepted the risk; if you leave it off, it's a breach of reps and they can claw back money from escrow. Your advisor organizes the data room so every claim is backed by a document.

The tail protects the advisor: a period (usually 12–24 months) after the engagement ends during which they still get paid if you sell to a buyer they introduced. The gotcha: ensure the tail applies only to a specific list of buyers the advisor actually contacted (the protected list). Don't sign a general tail that pays them if a totally new buyer approaches you later.

A Section 338(h)(10) election lets a stock sale be treated as an asset sale for tax purposes. Buyers love it — they step up the tax basis of your assets and save millions in future taxes. It often hurts you, converting capital gains to ordinary income rates on certain assets. The trade: if a buyer demands it, demand a tax gross-up — the buyer increases the purchase price to cover all of your incremental tax liability. You shouldn't lose a dollar to give them a tax break.

Lawyers draft; advisors negotiate business terms. By convention, buyer's counsel drafts the initial purchase agreement, giving them the pen. Your counsel marks it up; your advisor reviews the commercial sections — working capital peg, earnout calculations, escrow definitions. The auction-draft strategy: in a hot competitive process, seller's counsel drafts a form agreement and bidders submit price plus a markup of your document — anchoring the legal negotiation in your favor. It costs more upfront and only works with multiple bidders enforcing the leverage.

Secrecy is paramount. We use a need-to-know protocol: Codenames: your company is never named in initial outreach — it is "Project Falcon, a $10M ARR healthcare SaaS." The circle of trust: only the founders and perhaps the CFO/head of engineering know initially. We advise against telling broader management until after the LOI is signed. The partnership alibi: if employees see you meeting strangers or gathering data, frame it as fundraising or strategic partnership discussions — normal business activity.

Preparation is where 30–50% of final deal value gets created or lost, and it happens 12–18 months before launch. Financial: clean GAAP financials with 24 months of monthly detail, ARR bridge by cohort, retention analysis, customer concentration analysis, gross margin walk. Operational: org chart with dependencies, sales comp and quota data, documented go-to-market, 12-month roadmap, security posture (SOC 2, GDPR). Legal: clean cap table, contracts reviewed for change-of-control, IP ownership confirmed (including training data for AI companies), equity grants reviewed. The equity story: the most under-prepared element is the narrative itself — why this business commands a premium. The test: if you can't walk through your last 12 cohorts, top 10 customer dependencies, and GRR by quarter without notes, you're not ready to launch.

Deals rarely die because of the product; they die because of data discrepancies. Revenue recognition: you claimed $10M ARR, but GAAP says $8.5M because of how you booked setup fees. IP chain of title: a contractor wrote core code years ago but never signed an IP assignment. Sales tax liability: customers in 40 states with no sales tax collected (Wayfair). Open source violations: proprietary product relying on copyleft (GPL) code that legally requires open-sourcing your platform.

Yes, if your EBITDA is over $2M. A QofE is the financial audit a buyer normally uses to poke holes in your numbers. Hiring an accounting firm to do a sell-side QofE before going to market lets you find and fix the holes yourself and present a bulletproof number. It costs $30k–$60k but often saves $500k+ in re-trades later.

The Super Bowl of the process: a 2–4 hour strategic deep dive with the final 5–10 interested buyers covering market, product roadmap, unit economics, and growth plan. CEO, CTO, and head of sales attend (sometimes CFO). Buyers are betting on the team as much as the code — you must demonstrate command of your metrics and a credible vision for hitting the forecast.

Standard term: 45 to 60 days. Founder trap: avoid agreeing to 90+ days — time kills deals, and a long exclusivity period lets the buyer slow-roll diligence while they hunt for financing or get cold feet. Leverage: negotiate automatic termination of exclusivity if the buyer misses specific diligence milestones, keeping pressure on them to move fast.

Twelve to eighteen months before you actually want to close. Advisors add disproportionate value during preparation — fixing weak cohort stories, restructuring concentration risk, cleaning financials, pressure-testing the equity story. Starting early also enables strategic pre-positioning (a year of focus can genuinely fix weak metrics), buyer pre-warming, and optionality — a good advisor will tell you if the timing is wrong. The wrong trigger for engaging late: an inbound offer (run a process anyway).

Confirmatory diligence — the Death Valley phase. The buyer sends in accountants (QofE), tech auditors (code scan), and lawyers who read everything. Your top customers get verification calls (tightly controlled by the advisor). Lawyers fight over the purchase agreement; you build disclosure schedules. Reality: the deal feels like it is falling apart three times a week. Your advisor's job is to play therapist and firefighter to keep it on track.

Yes — until the LOI. That is the definition of creating a market. Your advisor might start with 50 buyers, run 10 management presentations, and receive 4 LOIs, negotiating them against each other. The limit: once you countersign one LOI, you enter exclusivity and must cease talks with all others.

Sophisticated buyers (especially PE) employ third-party code review firms to scan for security vulnerabilities, spaghetti code (scalability risk), and open source licensing issues. Preparation: run a preliminary scan (Synopsys, FOSSA) before the buyer does, so you can patch critical issues proactively.

A structured sell-side process typically runs 5 to 9 months from advisor engagement to close. Phase 1 — Preparation and data room (4–8 weeks): financial recasting, cohort analysis, CIM, data room. Skipping this phase is the most common cause of mid-process re-trades. Phase 2 — Buyer outreach and first-round bids (6–10 weeks): teasers, NDAs, CIM distribution, indications of interest across a 50–200 buyer list. Phase 3 — Management meetings and LOI (4–6 weeks): shortlisted buyers meet management; the advisor negotiates price, structure, and exclusivity. Phase 4 — Confirmatory diligence to close (8–12 weeks): legal, financial, technical, and AI-specific diligence; definitive agreement; closing. Founder bandwidth: a competitive process demands 20–40 hours/week of seller management without an advisor running interference — and distracted founders see metrics decline mid-process, which buyers re-trade on.

In a traditional process, founders describe it as a second full-time job — 20–30+ hours per week, a dangerous distraction. The modern approach: specialized advisors use AI-driven data extraction and pre-diligence teams to reduce founder involvement to under 10 hours per week. The founder is pulled in only for high-value strategy decisions and management presentations, shielded from the administrative burden so they can hit their quarterly numbers.

Synoptic M&A™ is iMerge Advisors' proprietary methodology that restructures the exit process from linear to parallel. The traditional way: prepare → market → LOI → then diligence starts, leading to late-stage surprises and re-trades when the founder has no leverage. The Synoptic way: critical workstreams run simultaneously. Predictive diligence identifies and fixes risks in weeks 1–4 (using AI tools) before buyers are contacted; front-loading legal and financial work shortens the exclusivity-to-close window. The result: processes often close in 3–5 months instead of 6–9, with higher likelihood of closing at the original offer price.

Run a competitive process. A single-buyer negotiation against a PE firm with full-time deal professionals structurally favors the buyer. What direct negotiation costs: a structured process across 50–200 buyers typically produces 20–40% higher valuations — on a $10M ARR company, the difference between 4x and 5.5x ARR dwarfs a 4–6% advisor fee. Direct negotiators also accept worse structure: aggressive earnouts, higher escrows, broader indemnification, longer non-competes. The approach: a good advisor folds your inbound buyer into a structured process. Now they're competing against three to five credible bids and must put their best price forward. The one exception: a trusted buyer offering all-cash, no earnout, minimal escrow, negotiated through experienced M&A counsel — and even then, you lack the leverage alternatives create.

It depends on the buyer type and terms negotiated. Strategic buyers often buy for talent — they may keep engineering/product teams but eliminate redundant G&A roles. Private equity typically keeps the entire team to drive growth, especially in platform deals. Protection: negotiate a retention pool (bonus fund) for key employees in the purchase agreement, and consider no-layoff clauses for a set period (e.g., 12 months).

Standard transition: 6 to 12 months to transfer knowledge and relationships. Key-man lockup: if you are critical to product vision, buyers may require a 2–3 year employment agreement. Clean break: in some cases you can negotiate a transition services agreement of just 3–6 months. Note: your earnout often dictates your tenure — if your payout depends on Year 2 revenue, you want to stay to ensure it happens.

Non-competes are standard and strictly enforced in M&A, typically 3 to 5 years, barring you from starting, investing in, or working for a competitive business. Negotiation tip: narrow the definition tightly. If you sell a dental CRM, ensure the non-compete only bans dental software, not all healthcare software — preserving your right to innovate in adjacent spaces.

Re-vesting keeps you motivated: the buyer holds back a portion of your proceeds (e.g., 25%) which you earn back over several years of continued employment. The pushback: you should be paid for the value you created — past tense. Future retention should be driven by new option grants, not by holding your own money hostage. Sophisticated advisors fight to minimize re-vesting.

Often where the real wealth is generated. You sell 80% for cash and roll 20% into the new PE-backed entity. PE firms aim to 3x their investment over five years — if they succeed, your rolled equity grows with it. Example: you sell for $20M, take $16M cash, roll $4M. The platform later sells for 3x; your $4M becomes $12M. Total exit: $28M.

If eligible, QSBS can save you millions: 100% federal tax exclusion on gains up to $10M or 10x your basis, whichever is greater. Rules: you must be a C-Corp (not LLC) for 5+ years with assets under $50M when the stock was issued. Warning: founders inadvertently break eligibility through bad entity conversions — run a QSBS audit early, before a buyer's tax team scrutinizes it.

Absorption vs. acceleration. Strategic buyer (absorption): they typically swallow you — your brand often disappears, your tech stack is migrated, your culture assimilated. Synergies are cost-driven. Private equity (acceleration): they optimize you. Your brand usually stays; they introduce playbooks for pricing, sales efficiency, and hiring, acting more like a board than a new boss as long as you hit KPIs.

Standard term: 12 to 18 months, typically 10–15% of the purchase price. It releases automatically after the term unless the buyer files a claim for breach of reps and warranties. Strategy: Reps & Warranties Insurance can reduce escrow to nearly zero (often 0.5% retention), putting more cash in your pocket at closing.

About 60–90 days after closing, accountants compare the estimated working capital at close vs. the actual balance. If you had less working capital than estimated, you write a check back to the buyer. Finalize these numbers early — agree on the math before the wire is sent, preventing surprise true-up payments that claw back founder value.

Many founders experience seller's remorse or a loss of identity post-close. Going from captain making 100 decisions a day to a middle manager in a large corporation (or unemployed) is a massive dopamine crash. The fix: plan your next act before you sign. Whether it's angel investing, a long sabbatical, or a new venture, a defined purpose post-close is critical.